Skip to main content
SpringerLink
Log in

Adverse events with high-intensity atorvastatin vs rosuvastatin

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Stein B, et al. Safety of High-Intensity Statins in the Veteran Population: Atorvastatin 40 to 80 mg Compared With Rosuvastatin 20 to 40 mg. Annals of Pharmacotherapy : 1060028019888487, 12 Nov 2019. Available from: URL: http://doi.org/10.1177/1060028019888487

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adverse events with high-intensity atorvastatin vs rosuvastatin. Reactions Weekly 1781, 4 (2019). https://doi.org/10.1007/s40278-019-71827-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-71827-4

Search

Navigation